米力农注射液治疗慢性肺心病合并呼吸衰竭的临床观察  

Clinical observation of Milrinone injection in the treatment of chronic cor pulmonale combined with respiratory failure

作　　者：耿玉青[1] Geng Yuqing(The Traditional Chinese Medicine Hospital of Linyi City in Shandong Province 276000)

机构地区：[1]山东省临沂市中医医院,276000

出　　处：《中国社区医师》2018年第22期74-74,76,共2页Chinese Community Doctors

摘　　要：目的:探讨米力农注射液治疗慢性肺心病合并呼吸衰竭患者的临床疗效。方法:收治慢性肺心病合并呼吸衰竭患者80例,随机分为两组,每组40例。对照组给予常规治疗,研究组在常规治疗基础上给予米力农注射液治疗,比较两组临床疗效、血气分析指标、肺动脉压。结果:研究组总有效率高于对照组,差异有统计学意义(P<0.05)。治疗后,研究组血气分析指标明显优于对照组,差异有统计学意义(P<0.05)。研究组治疗后肺动脉压明显低于对照组,差异有统计学意义(P<0.05)。结论:米力农注射液治疗慢性肺心病合并呼吸衰竭患者疗效显著,可明显改善临床症状和血气分析指标。Objective:To investigate the clinical effect of Milrinone injection in the treatment of chronic cor pulmonale combined with respiratory failure.Methods:80 cases of patients with chronic cor pulmonale combined with respiratory failure were divided into two groups randomly,with 40 cases in each group.The control group was given routine treatment,and the research group was treated with Milrinone injection on the basis of routine treatment,the clinical effect,blood gas analysis and pulmonary arterial pressure were compared between the two groups.Results:The total effective rate of the research group was higher than that of the control group,and the difference was statistically significant(P<0.05).After treatment,the blood gas analysis index of the research group was significantly better than that of the control group,the difference was statistically significant(P<0.05).The pulmonary artery pressure after treatment in the research group was significantly lower than that in the control group,the difference was statistically significant(P<0.05).Conclusion:Milrinone injection was effective in the treatment of chronic cor pulmonale combined with respiratory failure,which could improve clinical symptoms and blood gas analysis significantly.

关 键 词：米力农注射液 肺心病 呼吸衰竭 血气分析 肺动脉压 

分 类 号：R541.5[医药卫生—心血管疾病] R563.8[医药卫生—内科学]